Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study - PubMed (original) (raw)
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
A Hofman et al. Lancet. 1997.
Abstract
Background: Vascular disorders have been implicated in dementia, but whether atherosclerosis is related to the most frequent type of dementia, Alzheimer's disease, is not known. The apolipoprotein-E genotype has been associated with Alzheimer's disease, and we postulate that it plays a part, together with atherosclerosis, in the aetiology of Alzheimer's disease. We investigated the frequency of dementia and its subtypes in relation to atherosclerosis and apolipoprotein E.
Methods: We did a population-based study of 284 patients with dementia, 207 of whom had Alzheimer's disease, and 1698 individuals who were not demented. Indicators of atherosclerosis included vessel wall thickness and plaques of the carotid arteries, assessed by ultrasonography, and the ratio of ankle-to-brachial systolic blood pressure as a measure of generalised atherosclerosis. Based on these indicators participants were scored from 0 (no atherosclerosis) to 3 (severe atherosclerosis) for degree of atherosclerosis. Apolipoprotein-E polymorphisms were assessed in 246 patients and in 928 controls.
Findings: All indicators of atherosclerosis were associated with dementia (odds ratios ranging from 1.3 to 1.9) and its major subtypes Alzheimer's disease (odds ratios 1.3-1.8) and vascular dementia (odds ratios 1.9-3.2). The frequencies of all dementia. Alzheimer's disease, and vascular dementia increased with the degree of atherosclerosis. The odds ratio for Alzheimer's disease in those with severe atherosclerosis compared with those without atherosclerosis was 3.0 (95% CI 1.5-6.0; p = 0.001). In participants with the apolipoprotein-E epsilon 4 genotype and an atherosclerosis score of 2 or 3 the odds ratio for all dementia was 4.5 (2.0-10.1; p < 0.001), for Alzheimer's disease was 3.9 (1.6-9.6; p = 0.002), and for vascular dementia was 19.8 (4.1-95.0; p < 0.001).
Interpretation: These findings suggest that dementia and its two major subtypes Alzheimer's disease and vascular dementia are associated with atherosclerosis and that there is an interaction between apolipoprotein E and atherosclerosis in the aetiology of Alzheimer's disease.
Comment in
- Arteriosclerosis, apolipoprotein E, and Alzheimer's disease.
Kalaria RN. Kalaria RN. Lancet. 1997 Apr 19;349(9059):1174. doi: 10.1016/s0140-6736(05)63052-8. Lancet. 1997. PMID: 9113034 No abstract available.
Similar articles
- Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
Sleegers K, Roks G, Theuns J, Aulchenko YS, Rademakers R, Cruts M, van Gool WA, Van Broeckhoven C, Heutink P, Oostra BA, van Swieten JC, van Duijn CM. Sleegers K, et al. Brain. 2004 Jul;127(Pt 7):1641-9. doi: 10.1093/brain/awh179. Epub 2004 May 6. Brain. 2004. PMID: 15130954 - Atherosclerosis and risk for dementia.
van Oijen M, de Jong FJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. van Oijen M, et al. Ann Neurol. 2007 May;61(5):403-10. doi: 10.1002/ana.21073. Ann Neurol. 2007. PMID: 17328068 - Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM. Harrington CR, et al. Am J Pathol. 1994 Dec;145(6):1472-84. Am J Pathol. 1994. PMID: 7992850 Free PMC article. - Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers.
Zhong G, Wang Y, Zhang Y, Guo JJ, Zhao Y. Zhong G, et al. PLoS One. 2015 Mar 12;10(3):e0118333. doi: 10.1371/journal.pone.0118333. eCollection 2015. PLoS One. 2015. PMID: 25763939 Free PMC article. Review. - Blood pressure and dementia in the elderly: epidemiologic perspectives.
Guo Z, Viitanen M, Fratiglioni L, Winblad B. Guo Z, et al. Biomed Pharmacother. 1997;51(2):68-73. doi: 10.1016/s0753-3322(97)87729-3. Biomed Pharmacother. 1997. PMID: 9161470 Review.
Cited by
- Plasma proteomics-based brain aging signature and incident dementia risk.
Kou M, Ma H, Wang X, Heianza Y, Qi L. Kou M, et al. Geroscience. 2024 Nov 12. doi: 10.1007/s11357-024-01407-6. Online ahead of print. Geroscience. 2024. PMID: 39532828 - The Role of Copper in Alzheimer's Disease Etiopathogenesis: An Updated Systematic Review.
Sabalic A, Mei V, Solinas G, Madeddu R. Sabalic A, et al. Toxics. 2024 Oct 17;12(10):755. doi: 10.3390/toxics12100755. Toxics. 2024. PMID: 39453175 Free PMC article. Review. - Association between blood pressure and dementia in older adults: a cross-sectional study from China.
Yi T, Su Z, Wang J, Gan J, Wu H, Shi Z, Sun Z, Liu S, Ji Y. Yi T, et al. Front Aging Neurosci. 2024 Sep 11;16:1466089. doi: 10.3389/fnagi.2024.1466089. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39328244 Free PMC article. - Linking coronary artery disease to neurodegenerative diseases through systems genetics.
Vescio M, Pattini L. Vescio M, et al. Front Genet. 2024 Jul 25;15:1344081. doi: 10.3389/fgene.2024.1344081. eCollection 2024. Front Genet. 2024. PMID: 39119577 Free PMC article. - Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer's disease.
Liang N, Nho K, Newman JW, Arnold M, Huynh K, Meikle PJ, Borkowski K, Kaddurah-Daouk R; Alzheimer’s Disease Metabolomics Consortium. Liang N, et al. Sci Rep. 2024 Jul 29;14(1):17423. doi: 10.1038/s41598-024-67177-5. Sci Rep. 2024. PMID: 39075118 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical